跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAPENTADOL KRKA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAPENTADOL KRKA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
TAPENTADOL KRKA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 5, 2021
Approval ID
bec82e9eee6fb30f
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
bec82e9eee6fb30f
Drug Cima Aemps Name
TAPENTADOL KRKA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
86286
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2021-10-05
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Estupefacientes
Commercialized
Yes
Company Name
Krka D.D. Novo Mesto
Active Ingredients
TAPENTADOL MALEATO HEMIHIDRATO
234,76 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 5, 2021
Approval ID
bec82e9eee6fb30f
Type
Standard
Back to CIMA-AEMPS Approvals